Informations générales (source: ClinicalTrials.gov)
Importance of Left Ventricular Pacing Site in Biventricular Resynchronization Therapy for Severe Heart Failure
Interventional
N/A
University Hospital, Bordeaux (Voir sur ClinicalTrials)
novembre 2003
décembre 2007
29 juin 2024
Cardiac resynchronization therapy has been shown to be effective in reducing symptoms and
mortality in heart failure patients. However, very few is known about the importance of
the left ventricular pacing site. We study in a random order 11 different left
ventricular pacing sites and compare their hemodynamics using pressure-volume catheters.
The consequences on the surface ECG are also assessed.
Etablissements
| Les établissements hors Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
|---|---|---|---|---|---|
| Hôpital Cardiologique du Haut Lévêque, Rythmology department, Pr CLEMENTY, 3rd Floor - 33604 - Pessac - France | Pierre Jaïs, Dr | Contact (sur clinicalTrials) | |||
Critères
Tous
Inclusion Criteria:
- Heart failure referred for cardiac resynchronization therapy
- NYHA Class III or IV
- Informed consent form signed
- Heart failure referred for cardiac resynchronization therapy
- NYHA Class III or IV
- Informed consent form signed
- Hypertension not controlled by treatment
- Coronary ischemia not controlled by treatment